targeted therapy in egfr exon 20-mutant non–small cell lung cancer
Published 6 years ago • 1.2K plays • Length 5:50Download video MP4
Download video MP3
Similar videos
-
4:47
treating non–small cell lung cancer with an egfr exon 20 insertion
-
6:57
egfr exon 20 mutations in non–small cell lung cancer
-
5:53
targeted therapy in non-small cell lung cancer
-
32:15
a visual exploration of new targeted therapies for egfr exon 20 insertions in nsclc
-
0:52
targeted treatments for egfr exon 20 insertion mutations in nsclc
-
3:29
burden of egfr exon 20 mutation in nsclc
-
1:11
dr. gitlitz on egfr exon 20 insertion mutations in lung cancer
-
1:56
what targeted therapies are used for people with the egfr mutation?
-
13:47
egfr exon 20 mutations in nsclc
-
1:32
real-world comparison assesses mobocertinib in nsclc with egfr exon 20
-
1:49
addressing limitations in egfr exon 20-mutant nsclc
-
2:03
nsclc with egfr exon 20 shows benefit with mobocertinib over chemotherapy
-
5:55
a case of egfr-mutant non–small cell lung cancer
-
1:02
dr reckamp on amivantamab in egfr exon 20–mutated nsclc
-
1:46
the evolving treatment landscape for nsclc with egfr exon 20 insertion mutations
-
2:51
zenith20-5: poziotinib for egfr/her2 exon 20 mutant nsclc
-
3:49
zenith20: poziotinib in egfr and her2 exon 20 mutant nsclc
-
10:30
expert highlights: targeting her2 and egfr in nsclc | tejas patil
-
4:41
egfr exon-20 mutation - lung cancer video library